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Complex microbial communities reside within the intestines of hu-
mans and other vertebrates. Remarkably little is known about how
these microbial consortia are established in various locations within
the gut, how members of these consortia behave within their dy-
namic ecosystems, or what microbial factors mediate mutually ben-
eficial host–microbial interactions. Using a gnotobiotic zebrafish–
Pseudomonas aeruginosa model, we show that the transparency of
this vertebrate species, coupled with methods for raising these
animals under germ-free conditions can be used to monitor microbial
movement and localization within the intestine in vivo and in real
time. Germ-free zebrafish colonized with isogenic P. aeruginosa
strains containing deletions of genes related to motility and patho-
genesis revealed that loss of flagellar function results in attenuation
of evolutionarily conserved host innate immune responses but not
conserved nutrient responses. These results demonstrate the utility of
gnotobiotic zebrafish in defining the behavior and localization of
bacteria within the living vertebrate gut, identifying bacterial genes
that affect these processes, and assessing the impact of these genes
on host–microbial interactions.
Danio rerio  establishment of a gut microbiota  flagellar motility 
host–microbial symbiosis and mutualism  Pseudomonas aeruginosa
S tarting at birth, we are colonized by communities of micro-organisms that establish residency on our external and
internal surfaces. These resident microbes outnumber our hu-
man cells by an order of magnitude, and their aggregate genomes
(microbiome) specify important physiologic traits that are not
encoded in our own genome (1). The vast majority of these
microbes reside in our intestine: most of our 10–100 trillion
gut-dwelling microbes belong to the domain Bacteria, although
members of Archaea (Euryachaeota and Crenarchaeota) and
Eukarya are also represented (2–6). Over the last 50 years,
experiments comparing mice and rats raised in the absence of
any microorganisms [germ-free (GF)] to those colonized with
members of gut microbial communities have revealed that the
microbiota plays an integral role in many aspects of intestinal and
extraintestinal host biology, ranging from postnatal development
of the gut’s blood and lymphatic vascular systems (7, 8) to the
proliferative activity of intestinal epithelial cells (9, 10), metab-
olism of ingested xenobiotics (1, 11), regulation of energy
balance (12–14), maturation of the innate and adaptive immune
systems (15–18), heart size (19), and behavior (e.g., locomotor
activity) (14).
The notion that each of us is a supraorganism, composed of
microbial and human parts, focuses attention on the question of
how our microbial communities are assembled (20). Under-
standing the dynamic patterns of microbial entry into and
movement within their gut habitats is critical for deciphering
how different species establish and maintain a presence in the
intestinal ecosystem, and how they interact with their host and
other microbial community members. Fluorescence in situ hy-
bridization and confocal and electron microscopic analyses have
provided static rather than dynamic views of the positioning of
microbial cells within the mammalian intestine, and in vivo
bioluminescence analyses do not permit resolution of individual
microbial cells.
The zebrafish (Danio rerio) possesses several key attributes
that make it a distinctively powerful model organism for ad-
dressing these questions. First, the zebrafish digestive tract is
structurally similar to that of mammals, with proximal-distal
specification of functions and multiple self-renewing epithelial
cell lineages (21, 22). Second, comparisons of GF zebrafish and
those colonized with a microbiota harvested from the intestines
of conventionally raised (CONV-R) zebrafish or mice have
revealed a broad range of host processes that are impacted by the
gut microbiota and that are conserved between mammals and
fish (23–25). Moreover, individual bacterial representatives of
the zebrafish and mouse gut microbiotas have been identified
that can provoke evolutionarily conserved host responses in
gnotobiotic zebrafish (23–25). Third, this vertebrate species and
its gut are optically transparent from the time of fertilization
through the onset of adulthood. This unusual feature provides an
opportunity to make real-time in vivo observations of microbial–
microbial and microbial–host interactions. Because zebrafish
larvae can be grown in a 96-well plate format, their transparency
could also be used to conduct genetic and chemical screens for
host and/or microbial factors that mediate host–microbial inter-
actions. Finally, with the development of methods for rearing
zebrafish under GF conditions, reciprocal transplantations of
gut communities from normal mouse and zebrafish donors into
GF zebrafish and mouse recipients have revealed that differ-
ences in the normal gut communities of these vertebrates arise
in part from distinct selective pressures imposed within their
respective gut habitats. These experiments also revealed a
striking degree of conservation of host responses to the different
microbiotas (24).
We have used a simplified system, consisting of GF zebrafish
colonized with the Gram-negative -proteobacterium Pseudo-
monas aeruginosa, to define the mechanisms by which mem-
bers of the microbiota elicit these conserved host responses. P.
aeruginosa is best known as an opportunistic pathogen. How-
ever, it has several characteristics that facilitate its use as a
model mutualist in this system. Pseudomonads are common
members of the fish gut microbiota (23–28) as well as the gut
microbiota of some mammals (e.g., the African zebra and
others; R. E. Ley and J.I.G, unpublished observations) [see
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supporting information (SI) Materials and Methods and Fig. 4
for a 16S rRNA sequence-based tree of zebrafish Pseudo-
monads and their relationship to P. aeruginosa]. Although
Pseudomonads are rare members of the intestinal microbiota
of healthy humans, their representation is increased in certain
pathologic states, notably inf lammatory bowel diseases (29–
31). In an initial survey, 10 different bacterial species repre-
sentative of the zebrafish or mouse gut microbiota were tested
for their ability to elicit the innate immune and nutrient
metabolic responses produced when a complete microbiota is
introduced into GF zebrafish hosts. In this survey, P. aerugi-
nosa was the most potent inducer of these responses (24) (see
SI Fig. 5). Finally, in addition to the large body of knowledge
that exists about P. aeruginosa biology, valuable genetic re-
sources are available, including a finished genome sequence
for strain PAO1 (32), deep draft genome assemblies for several
other strains (PA14, C3719, 2192, PA7, and PACS2), and
saturation-level sequenced transposon insertion libraries for
strains PAO1 (33) and PA14 (34).
In the present study, we take advantage of the transparency of
zebrafish and these genetic resources to demonstrate a linkage
between motility/f lagellar function and regulation of conserved
innate immune responses.
Results
Real-Time in Vivo Imaging of Microbial Consortia and Individual
Bacterial Species in the Transparent Intestine of Gnotobiotic Ze-
brafish. As noted above, the transparency of the zebrafish
provides opportunities for exploring the movement as well as
localization of microbes within their intestinal habitat through
real-time microscopy of live whole-mount zebrafish. CONV-R
zebrafish typically hatch from the GF environment within their
protective chorions at 3 days postfertilization (dpf). This hatch-
ing event coincides with the anterior digestive tract achieving full
patency (21, 35). Fluorescence in situ hybridization has revealed
that the zebrafish digestive tract is colonized by bacteria as early
as 4 dpf (25); however, the timing and route of initial coloniza-
tion remained unclear.
Therefore, we first colonized GF zebrafish at 3 dpf with a
normal zebrafish microbiota harvested from adult CONV-R
zebrafish (a process called conventionalization) and then imaged
their digestive tracts at different time points. In vivo bright-field
microscopy of the gut microbiota in these conventionalized
(CONVD) animals revealed a striking amount of microbial
movement within their intestinal lumen (SI Movies 1 and 2),
although the activity of individual microorganisms was difficult
to monitor.
Upon exposure to P. aeruginosa, 3-dpf GF zebrafish are
colonized at densities similar to the conventional zebrafish gut
microbiota (104-105 cfu per gut at 6 dpf; SI Table 1) and elicit
host responses that are conserved across vertebrate hosts (see
below and ref. 24). To facilitate real-time in vivo microscopic
observation of individual microbial cells, we introduced a plas-
mid that allows constitutive expression of the gene encoding
GFP under the control of the trc promoter (pMF230) (36) into
P. aeruginosa strain PAO1 to create PAO1 pMF230. GF 3-dpf
zebrafish exposed to 104 cfu of P. aeruginosa PAO1 pMF230/ml
gnotobiotic zebrafish medium (GZM) were initially colonized
with a small cohort of bacteria that was readily seen as early as
3.5 dpf (Fig. 1 A and D and SI Movie 3). Because the anus does
not achieve patency until 4 dpf (21, 35), our findings establish
that the anterior digestive tract becomes colonized within just a
few hours after its lumen first opens.
The size of this monocomponent community increased rapidly
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Fig. 1. Gut bacteria display diverse behaviors within the intestines of gnotobiotic zebrafish. (A and D) Whole-mount preparation of a live 3.5-dpf zebrafish
colonized since 3 dpf with GFP-expressing P. aeruginosa PAO1 (PAO1 pMF230) demonstrates the transparency of the developing zebrafish intestine. Brightfield
microscopy of the anterior intestine (segment 1, A) shows the intestinal lumen (lum) and the adjacent intestinal epithelium (ep). Fluorescence time-lapse
microscopy of the same field (D) shows the movements of individual bacteria over the course of 10 frames, or 4 sec (D extracted from SI Movie 3). The locations
of individual bacteria in the first (1) and the last (10) frames are numbered accordingly. (B and E) Brightfield (B) and fluorescence time-lapse (E) microscopy of
the same field from a live 6-dpf zebrafish, colonized since 3 dpf with PAO1 pMF230, shows increasing bacterial density and behavioral complexity in the
midintestine (junction of segments 1 and 2) over the course of 10 frames or 2.6 sec (E extracted from SI Movie 4). Note that the intestines shown in D and E both
contain bacteria that are nonmotile in association with the host epithelium or luminal contents (yellow), whereas other bacteria exhibit high rates of motility
in both ascending (distal to proximal; red tracks) and descending (green tracks) directions. Note that ascending and descending bacteria were tracked for only
the first several frames because they quickly moved out of the focal plane; the first and last frames over which bacteria were tracked are numbered. (C and F)
Brightfield (C) and fluorescence time-lapse (F) microscopy of a live 4.5-dpf zebrafish colonized since 3 dpf with DsRed-expressing E. coli MG1655 (MG1655 pRZT3)
showing movement of luminal bacteria (green tracks) in the midintestine (segment 1). Over the course of 14 frames or 14 sec (F extracted from SI Movie 5), some
bacteria appear adherent to the epithelium or luminal structures (yellow track), whereas most bacterial motion is synchronous and attributed to intestinal
motility (green tracks). Anterior is to the left, and dorsal is to the top in all images. (Scale bars: 20 m.)









over the course of the next 2.5 days. As in CONVD zebrafish,
bacteria in 6-dpf P. aeruginosa monoassociated zebrafish were
observed along the entire proximal-distal length of the intestine
(e.g., SI Movie 4). Individual bacteria displayed a range of
behaviors, from intimate association with the intestinal epithe-
lium, to incorporation into large multicellular structures in the
luminal space, to rapid movement of planktonic cells through the
lumen (Fig. 1 B and E and SI Movie 4). In 6-dpf hosts, individual
bacteria were observed moving at speeds as high as 24 m/sec
within the lumen (equivalent to 12 body lengths per sec). This
movement is likely the result of f lagella-mediated swimming
motility (see below).
A central challenge for members of a gut microbiota is to avoid
washout from its continuously perfused ecosystem. Static scan-
ning electron microscopic studies in the gnotobiotic mouse
intestine indicate this can be achieved by bacterial attachment to
nutrient platforms consisting of partially digested food particles,
exfoliated fragments of mucus, and shed epithelial cells (37, 38).
From an engineering perspective, these platforms represent well
settling particles, analogous to those that prevent microbial
washout from human-made bioreactors (37).
Our gnotobiotic zebrafish provided a dynamic view of the
interactions of bacteria with such luminal contents. Similar to the
microbiota in CONV-R and CONVD zebrafish, PAO1 pMF230
was observed interacting with large slowly moving luminal
structures (SI Movie 2 and data not shown) that were distributed
along the length of the gut lumen; similar masses were observed
in GF animals, indicating that their formation does not depend
upon microbes. Individual bacterial cells could be seen inter-
mittently contacting the surface of these masses (SI Movie 2).
To determine whether bacteria reside within these structures,
we fixed P. aeruginosa PAO1 monoassociated 6-dpf zebrafish en
bloc and processed them for transmission electron microscopy
(TEM): this en bloc fixation was designed to minimize disruption
of the in vivo spatial relationships among microbes, other gut
contents, and host cells. Transverse TEM sections through the
zebrafish intestine revealed that the luminal masses contained
many intact bacteria mixed with other gut contents, including
mucus-like material and large electron-dense lamina (Fig. 2A
and B). Consistent with our real-time in vivo imaging results,
bacterial cells were also observed outside these luminal aggre-
gates in close juxtaposition to the host epithelium (Fig. 2 A).
TEM disclosed that in CONV-R, CONVD, and P. aeruginosa-
monoassociated zebrafish, actively dividing and nondividing
bacterial cells were closely associated with epithelial cells in the
intact mucosa and in the luminal structures (Fig. 2C plus data not
shown) (23).
Together, these findings show that P. aeruginosa appears to
recapitulate the range of movements, as well as the locations
occupied by members of the intestinal microbiota. To investigate
whether the behavior of P. aeruginosa in this system was char-
acteristic of other -Proteobacteria, we colonized 3-dpf GF
zebrafish with Escherichia coli MG1655 carrying a plasmid that
directs constitutive expression of red f luorescent protein
(DsRed) under the control of the lac promoter (MG1655
pRZT3). Strain MG1655 pRZT3 displayed significantly less
motility than strain PAO1 pMF230 in 6-dpf zebrafish digestive
tracts (Fig. 1 E and F and SI Movies 4 and 5), even though its
density of colonization was not significantly different from P.
aeruginosa (SI Table 1). In contrast, in vitro assays revealed that
E. coli MG1655 has higher rates of swimming motility than P.
aeruginosa PAO1 in soft agar (SI Fig. 6), suggesting that the
zebrafish gut environment influences motility in these bacterial
species.
Characterization of P. aeruginosa as a Model Zebrafish Mutualist. P.
aeruginosa strains generally express one of two flagellin proteins
(type-a and -b flagellin) that differ by 35% in amino acid
sequence (39). To determine whether the motility phenotype
and other effects on the host were specific to type-b strains such
as PAO1, we tested a well characterized P. aeruginosa strain that
expresses type-a flagellin (strain PAK) (40). Both strains colo-
nized the digestive tracts of GF zebrafish to similar densities (SI
Table 1) and were highly motile in vivo (SI Movies 3 and 4 and
data not shown). Moreover, both strains elicited evolutionarily
conserved nutrient and innate immune responses: quantitative
RT-PCR (qRT-PCR) assays conducted on RNA extracted from
whole 6-dpf monoassociated zebrafish indicated they suppressed
expression of fiaf [also known as angptl4; encodes a secreted
inhibitor of lipoprotein lipase (12, 41)] and carnitine palmitoyl-
transferase 1a (cpt1a; involved in mitochondrial oxidation of fatty
acids) and induced expression of serum amyloid a (saa; an
acute-phase protein) and myeloperoxidase (mpo; a granulocyte-
specific biomarker of the innate immune response to the normal
gut microbiota) (23, 24) (Fig. 3 and SI Table 2).
Animal models of P. aeruginosa infection and disease have
identified specific factors that this bacterium uses for virulence.
A multicomponent Type III secretion system (TTSS) functions
to translocate effector proteins into host cells. Strains PAO1 and
PAK both secrete three effectors by the TTSS (ExoS, ExoT, and
ExoY); these toxins target various host signaling pathways,




Fig. 2. TEM of gut bacteria in gnotobiotic zebrafish. Transverse sections are
shown that include segments 1 and 2 of the intestine of a 6-dpf zebrafish
colonized since 3 dpf with P. aeruginosa strain PAO1. (A) Bacteria are clustered
together in the luminal space, and some remain close to the host epithelium
(arrowhead inA). (BandC)Bacteria (arrowheads)arealsoobserved inassociation
with unidentified electron-dense laminated objects in the lumen (arrows in B)
and undergoing fission (C). (Scale bars: A, 3 m; B, 1 m; C, 500 nm.)
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(42). The TTSS is required for colonization and virulence in a
range of mouse models of infection (43–45).
To test whether these gene products play a role in P. aeruginosa
colonization of the zebrafish gut, we exposed GF 3-dpf zebrafish
to the PAK strain carrying a deletion for the TTSS master
transcriptional regulator exsA (46). In many of the pathogenesis
models of P. aeruginosa infection, this mutant exhibits decreased
virulence and colonization (43, 47, 48). In contrast, the wild-type
and exsA mutant strains achieved comparable densities of col-
onization within the intestines of 6-dpf zebrafish (SI Table 1),
indicating that the TTSS and its secreted toxins are not essential
for colonization. In addition, qRT-PCR analysis showed that the
exsA mutant strain was capable of regulating expression of fiaf,
cpt1a, saa, and mpo in a manner that was not significantly
different from its wild-type parent strain (Fig. 3).
P. aeruginosa uses the RetS hybrid two-component system to
coordinately activate TTSS expression and repress exopolysac-
charide production (49). Similar to exsA mutants, deletion of retS
leads to loss of the TTSS. In addition, these mutants overproduce
exopolysaccharides implicated in biofilm formation (49). To
ascertain whether overproduction of these exopolysaccharides
influenced P. aeruginosa–zebrafish interactions, we introduced
an isogenic PAK retS mutant strain into 3-dpf GF hosts. As with
the TTSS mutant, neither colonization density nor the response
of host innate immune and nutrient biomarker genes differed
between the mutant and wild-type strains when measured at 6
dpf (Fig. 3 and SI Table 1).
P. aeruginosa utilizes several surface appendages for coloni-
zation and virulence, including a single polar flagellum and Type
IV pili. To test the role of bacterial movement on host responses,
we examined isogenic PAK strains with loss-of-function muta-
tions in fliC and pilA (40, 50). The flagellar apparatus of P.
aeruginosa is assembled through an intricate regulatory process,
concluding with synthesis and assembly of FliC protein into the
flagellar filament (40, 51). Transmembrane ion gradients pro-
vide energy for physical rotation of the filament by the flagellar
motor (51). The motor consists of two structures: the rotor (the
switch that determines direction of rotation) and the stator (the
stationary component through which the rotor turns). Because
FliC is the major structural component of the flagellar filament,
the fliC mutant fails to assemble an intact f lagellar filament (40,
51, 52). The pilA mutant, which is missing the major pilin
structural subunit, does not exhibit pili-dependent twitching or
swarming motility (53).
Both mutants achieved a normal density of colonization in the
zebrafish gut (SI Table 1). However, the fliC strain did not show the
highly motile phenotype characteristic of wild-type P. aeruginosa in
this habitat or in vitro (SI Fig. 6 and data not shown), suggesting that
swimming motility is a primary method of locomotion in vivo.
qRT-PCR assays revealed that, like wild-type P. aeruginosa, the fliC
and pilA mutants were able to suppress expression of the nutrient
metabolic biomarkers fiaf and cpt1a in 6-dpf larvae (Fig. 3). Unlike
the wild-type or three other mutant strains, fliC-deficient bacteria
failed to elicit a significant increase in expression of innate immune
response biomarkers saa or mpo (reference controls, GF 6-dpf
animals; Fig. 3).
The attenuated host immune responses to fliC mutants could
be caused by absence of FliC protein, the absence of an intact
f lagellar filament, and/or the absence of flagellar function. To
help distinguish among these possibilities, we colonized 3-dpf
GF zebrafish with a P. aeruginosa PAK strain that carries
deletions of the motAB and motCD genes (motABCD), encod-
ing the bacterium’s two flagellar stators. PAK motABCD mu-
tants assemble an intact f lagellar filament that contains the FliC
protein, but the assembled filament is nonmotile (SI Fig. 6)
because of a failure of filament rotation (54, 55). As with the fliC
mutant, we found that the motABCD mutant was able to colonize
6-dpf zebrafish at densities comparable to the isogenic wild-type
strain (SI Table 1) and to recapitulate its elicited nutrient
responses: thus, f lagellar motility is not required for these host
reactions to colonization (Fig. 3). Also similar to fliC mutants,
innate immune responses to motABCD mutants in 6-dpf ze-
brafish larvae were significantly attenuated (Fig. 3). Therefore,
the ability of P. aeruginosa to evoke these conserved innate
immune responses to a complete gut microbiota is due in part to
flagellar function, rather than exclusively to the presence of an
intact f lagellar filament and its component proteins such as FliC.
Discussion
For P. aeruginosa and other bacteria, flagella perform several
nonexclusive functions that can impact bacterial colonization and
host responses in the digestive tract. First, flagella mediate swim-
ming motility that can facilitate interactions with and invasion of
host cells (56), as well as chemotaxis toward preferred habitats and
nutrient sources (57) [e.g., studies of V. cholerae mutants indicate
bacterial motility and chemotaxis are important virulence deter-
minants in the (mouse) intestine (58)]. Second, flagella can act as
adhesins that bind bacteria to host epithelial cells independent of
their role in motility (59, 60). Third, flagella can serve as a secretion
apparatus for virulence factors (61, 62), a role that may be played
by P. aeruginosa flagella (63). Finally, flagellin can serve as a major
immunostimulatory antigen recognized by Toll-like receptor 5
(TLR5) homologs in both fish and mammals (64–66). Activation of
mammalian TLR5 triggers NF-B-dependent proinflammatory
signaling pathways that stimulate production of acute-phase pro-
teins and neutrophil chemoattractants (67, 68). P. aeruginosa fla-
gella can also bind the glycolipid asialoGM1, leading to TLR2-
dependent activation of similar signaling pathways (69). Recent
studies have revealed that flagellin from other bacterial species can
also be detected by TLR5-independent mechanisms (70).
Our observations suggest that flagellar function, including the
swimming motility observed by real-time in vivo microscopy, is
an important component of host–bacterial interaction in this

















































Fig. 3. The impact of P. aeruginosa flagellar mutants on host responses in
gnotobiotic zebrafish. Expression levels of serum amyloid a (saa), myeloperoxi-
dase (mpo), fasting-induced adipose factor (fiaf ), and carnitine palmitoyltrans-
ferase 1a (cpt1a) were assessed by qRT-PCR by using RNA extracted from whole
6-dpf larvae colonized since 3 dpf with P. aeruginosa PAK wild-type strain, PAK
exsA deletion mutant (PAK exsA), PAK retS deletion mutant (PAK retS), PAK
pilA deletion mutant (PAK pilA), PAK fliC deletion mutant (PAK fliC), or PAK
motABCD deletion mutant (PAK motABCD). Data from biological duplicate
pools (6–17 animals per pool) were normalized to 18S rRNA levels. Normalized
mRNA levels in colonized fish were referenced against age-matched GF controls
(Ct method), and the results are expressed as mean percent change relative to
the PAK wild-type strain  SEM. ***, P  0.0001; **, P  0.001 compared with
wild-type, based on a two-tailed Student’s t test.
.









tility promotes physical interaction between P. aeruginosa and
the host epithelium, where the presence of surface-attached
antigens (including the flagellum itself) and other bacterial
products can be monitored by the host. Although it remains
possible that flagella-dependent immune responses are ulti-
mately stimulated by FliC acting as an antigen, the attenuated
immune response to the flagellated but nonmotile motABCD
mutant shows that flagella motor function is required for this
process to occur. These observations set the stage for future
experiments that further dissect how dynamic interactions be-
tween P. aeruginosa and the gut epithelium mediate the observed
flagellar-motility-dependent host response in zebrafish.
Our results demonstrate the utility of using gnotobiotic ze-
brafish for defining and monitoring microbial behavior and
localization within the living vertebrate gut and for identifying
bacterial genes that affect host–microbial interactions. As such,
this genetically pliable host provides an opportunity to explore
how habitat influences the establishment of a microbiota, and
how microbial dynamics in vivo affect host biology. Although P.
aeruginosa is often used as a model opportunistic pathogen, our
study indicates that it can also serve as a model mutualist,
capable of colonizing the gut of gnotobiotic zebrafish and
eliciting nutrient metabolic and innate immune responses that
have been conserved during the 400 million years since fish and
mammals diverged from their last common ancestor. The com-
bined advantages of P. aeruginosa (genome sequence, saturation-
level insertion libraries, and genetic tools) and gnotobiotic
zebrafish (conservation of metabolic and immune responses to
a microbiota with mammals, amenability to high-throughput
genetic and chemical screens and the ability to directly observe
the gut and its microbial inhabitants in a living vertebrate) offer
an opportunity to systematically decipher the foundations of
host–microbial mutualism in the gut and perhaps to apply the
findings to our own species.
Materials and Methods
Animal Husbandry. All experiments using zebrafish were per-
formed by using protocols approved by the Animal Studies
Committees of Washington University and the University of
North Carolina at Chapel Hill.
Zebrafish gametes were expressed manually from CONV-R
adults (C32 inbred strain), fertilized in vitro, and embryos
derived as GF according to established protocols (23). GF
zebrafish were reared under a 14-h light cycle in sterile vented
tissue culture flasks (Becton Dickinson, Sparks, MD) at an
average density of 1.3 individuals per milliliter of GZM (GZM
components are defined in ref. 23). Animals were maintained at
28.5°C in an air incubator. Fish were fed daily beginning at 3 dpf
with a sterilized solution containing 0.1 mg of ZM000 fish food
(ZM Ltd., Winchester, United Kingdom) per milliliter of GZM.
A 90% water change was performed before each daily feeding,
starting at 3 dpf. GF zebrafish were monitored routinely for
sterility by using culture-based methods (23).
Colonization and in Vivo Imaging. At the time of hatching at 3 dpf,
we exposed GF zebrafish reared in sterile vented tissue culture
flasks to (i) an unfractionated gut microbiota harvested directly
from CONV-R adult C32 donors, (ii) P. aeruginosa PA01
containing pMF230 [harbors GFP under the control of a con-
stitutive trc promoter (36); supplied by Michael Franklin, Mon-
tana State University, Bozeman, MT], (iii) E. coli MG1655
containing pRZT3 (DsRed under the control of a constitutive
lac promoter; a gift from Wilbert Bitter, Vrije University Med-
ical Centre, Vrije, The Netherlands), (iv) wild-type P. aeruginosa
PAK or the isogenic fliC strain carrying pSMC21 [a derivative
of pSMC2 (71), harboring GFP under the control of a consti-
tutive lac promoter; provided by Matthew Wolfgang, University
of North Carolina, Chapel Hill], or (v) isogenic wild-type or
mutant P. aeruginosa PAK strains without plasmids (supplied by
Matthew Wolfgang and Reuben Ramphal, University of Florida,
Gainesville, FL; plus Stephen Lory, Harvard University, Boston,
MA). Bacterial strains were grown overnight at 37°C in Luria–
Bertani broth before inoculation. Microbes were introduced at
a density of 104 cfu/ml GZM. A complete list of bacterial strains
and plasmids used can be found in SI Table 1.
Monoassociated and age-matched CONVD zebrafish were
imaged at various times after exposure to bacteria by using the
following protocol. Animals were anesthetized in 0.2 mg/ml
Tricaine (Sigma, St. Louis, MO), placed on a 40  22-mm glass
coverslip, and imbedded in low-melting-point 1% NuSieve GTG
agarose (FMC Bioproducts, Philadelphia, PA) containing 0.2
mg/ml Tricaine anesthetic. After the agarose quickly solidified,
animals were viewed by using an Axiovert 200M inverted
fluorescence microscope and Axiovision 4.1 software (Zeiss,
Thornwood, NY).
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